Figure 2. Outcome in pediatric T-ALL patients treated with the Turkish-BFM protocol. A. OS according to TAL1/LYL1/LMO2 expression.B. RFS according to TAL1/LYL1/LMO2 expression. C. OS according to TLX1/TLX3 expression. D. RFS according to TLX1/TLX3 expression. E. OS according to TAL1/LYL1/LMO2/TLX1/TLX3/BMI1 expression. F. RFS according to TAL1/LYL1/LMO2/TLX1/TLX3/BMI1 expression. P value ≤0.05 (two sided) was considered indicative of a statistically significant difference. None of the Kaplan-Meier analyses showed significant differences.